参考文献/References:
[1] Gordin EA, Luginbuhl AL, Ortlip T. Subcutaneous vs intramuscular botulinum toxin: split-face randomized study[J]. JAMA Facial Plast Surg,2014,16(3): 193-198.
[2] Gart MS,Gutowski KA.Overview of botulinum toxins for aesthetic uses[J]. Clin Plast Surg,2016 ,43(3):459-471.
[3] Jeong HS , Lee BH , Sung HM,et al. Effect of botulinum toxin type A on differentiation of fibroblasts derived from scar tissue[J]. Plast Reconstr Surg, 2015, 136 (2): 171e-178e.
[4] Hsu KC, Luan CW, Tsai YW. Review of silicone gel sheeting and silicone gel for the prevention of hypertrophic scars and keloids[J]. Wounds,2017,29(5):154-158.
[5] Elhefnawy AM. Assessment of intralesional injection of botulinum toxin type A injection for hypertrophic scars Indian[J] .Dermatol Venereol Leprol,2016, 82 (3) :279-283.
[6] Zhao J, Liu YC, Shi YH .Role of rat autologous skin fibroblasts and mechanism underlying the repair of depressed scars[J]. Exp Ther Med, 2016, 12 (2): 945 -950.
[7] Haubner F, Leyh M, Ohmann E, et al.Effects of botulinum toxin A on patient-specific keloid fibroblasts in vitro[J]. Laryngoscope ,2014, 124(6): 1344 -1351.
[8] Kiritsi D, Nystrom A.The role of TGFβ in wound healing pathologies[J]. Mech Ageing Dev, 2018, 172:51-58.
[9] Olmos-Zuniga JR, Silva-Martínez M, Jasso-Victoria R.Effects of pirfenidone and collagen-polyvinylpyrrolidone on macroscopic and microscopic changes, TGF-β1 expression, and collagen deposition in an experimental model of tracheal wound healing[J]. Biomed Res Int, 2017,17(2):6471071.
[10] Zhai XX, Tang ZM, Ding JC, et al.Expression of TGF-β1/mTOR signaling pathway in pathological scar fibroblasts[J].Mol Med Rep,2017, 15 (6):3467-3472.